Insights from 2023 ASH Annual Meeting
Playback speed
10 seconds
CLL/SLL Treatment With Post-cBTKi Pirtobrutinib: 30 Months Follow-Up & Subgroup Analysis With/Without Prior BCL2i From the Ph1/2 BRUIN Study
By
Insights from 2023 ASH Annual Meeting
FEATURING
Jennifer Woyach
By
Insights from 2023 ASH Annual Meeting
FEATURING
Jennifer Woyach
397 views
December 19, 2023
Login to view comments.
Click here to Login
Leukemia